TEVA PHARMACEUTICAL INDS LTD's ticker is and the CUSIP is 881624959. A total of 6 filers reported holding TEVA PHARMACEUTICAL INDS LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $858,000 | +464.5% | 350,000 | +483.3% | 0.01% | +700.0% |
| Q4 2019 | $152,000 | -53.9% | 60,000 | 0.0% | 0.00% | -66.7% |
| Q3 2019 | $330,000 | -86.1% | 60,000 | -80.9% | 0.00% | -81.2% |
| Q2 2019 | $2,372,000 | +176.1% | 314,000 | -19.3% | 0.02% | +100.0% |
| Q1 2019 | $859,000 | -81.0% | 389,000 | -71.4% | 0.01% | -80.0% |
| Q4 2018 | $4,529,000 | +153.2% | 1,360,000 | +11.5% | 0.04% | +207.7% |
| Q3 2018 | $1,789,000 | +1541.3% | 1,220,000 | +300.0% | 0.01% | +1200.0% |
| Q2 2018 | $109,000 | -92.2% | 305,000 | -43.5% | 0.00% | -90.9% |
| Q1 2018 | $1,394,000 | -9.1% | 540,000 | -24.7% | 0.01% | -21.4% |
| Q4 2017 | $1,534,000 | +196.7% | 717,400 | +941.2% | 0.01% | +180.0% |
| Q3 2017 | $517,000 | +538.3% | 68,900 | -44.9% | 0.01% | +400.0% |
| Q2 2017 | $81,000 | -59.3% | 125,000 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $199,000 | -78.4% | 125,000 | +20.2% | 0.00% | -75.0% |
| Q4 2016 | $920,000 | -43.2% | 104,000 | -59.1% | 0.01% | -52.9% |
| Q3 2016 | $1,619,000 | +268.8% | 254,000 | +34.4% | 0.02% | +466.7% |
| Q2 2016 | $439,000 | +348.0% | 189,000 | +278.0% | 0.00% | +200.0% |
| Q1 2016 | $98,000 | +512.5% | 50,000 | -50.0% | 0.00% | – |
| Q4 2013 | $16,000 | -90.8% | 100,000 | 0.0% | 0.00% | -100.0% |
| Q3 2013 | $173,000 | -5.5% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $183,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,416 | $7,611,000 | 0.29% |
| Timber Hill LLC | 242,600 | $13,040,000 | 0.05% |
| PEAK6 Group LLC | 50,100 | $2,693,000 | 0.02% |
| Virtu KCG Holdings LLC | 6,800 | $366,000 | 0.01% |
| Elite Wealth Management, Inc. | 63 | $0 | 0.00% |